Identifying New Targets for Endometrial Cancer Treatment
Author Information
Author(s): Voisin Sébastien N., Krakovska Olga, Matta Ajay, DeSouza Leroi V., Romaschin Alexander D., Colgan Terence J., Siu K. W. Michael
Primary Institution: York University
Hypothesis
Can a drill-down proteomics approach identify novel molecular targets for endometrial cancer diagnosis and treatment?
Conclusion
The study successfully identified several novel molecular targets that could improve diagnosis and treatment strategies for endometrial cancer.
Supporting Evidence
- A total of 1529 proteins were identified, with 40 showing significant differential expression in endometrial cancer compared to normal tissues.
- The drill-down approach improved the identification of proteins by allowing for iterative analysis of the same sample.
- Network analyses indicated that the identified proteins are regulated by key oncogenic pathways.
Takeaway
Researchers found new proteins that could help doctors diagnose and treat a type of cancer in women's reproductive organs by using a special testing method.
Methodology
The study used a drill-down proteomics approach with iTRAQ to analyze endometrial cancer tissues and identify differentially expressed proteins.
Potential Biases
Potential bias in labeling efficiency between individual versions of the iTRAQ tags.
Limitations
The analyses were not performed on identical samples, which may affect the standard deviation in quantitative analysis.
Participant Demographics
10 endometrial carcinoma cases and 10 normal proliferative endometrium samples were analyzed.
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website